Jee Bang


If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 1 Similar Profiles
Progressive Supranuclear Palsy Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences
Intracranial Aneurysm Medicine & Life Sciences
Infected Aneurysm Medicine & Life Sciences
Frontotemporal Dementia Medicine & Life Sciences
Placebo Effect Medicine & Life Sciences
Inborn Genetic Diseases Medicine & Life Sciences
Prion Diseases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2017

Potential biomarker breakthrough for Huntington's disease

Ross, C. A. & Bang, J., Aug 1 2017, In : The Lancet Neurology. 16, 8, p. 573-574 2 p.

Research output: Contribution to journalComment/debate

Huntington Disease

Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy

AL-108-231 Investigators, Jul 1 2016, In : Parkinsonism and Related Disorders. 28, p. 29-35 7 p.

Research output: Contribution to journalArticle

Progressive Supranuclear Palsy

Genetic prion disease caused by PRNP Q160X mutation presenting with an orbitofrontal syndrome, cyclic diarrhea, and peripheral neuropathy

Fong, J. C., Rojas, J. C., Bang, J., Legati, A., Rankin, K. P., Forner, S., Miller, Z. A., Karydas, A. M., Coppola, G., Grouse, C. K., Ralph, J., Miller, B. L. & Geschwind, M. D., 2016, In : Journal of Alzheimer's Disease. 55, 1, p. 249-258 10 p.

Research output: Contribution to journalArticle

Inborn Genetic Diseases
Prion Diseases
Peripheral Nervous System Diseases
Nonsense Codon

Plasma neurofilament light chain predicts progression in progressive supranuclear palsy

Rojas, J. C., Karydas, A., Bang, J., Tsai, R. M., Blennow, K., Liman, V., Kramer, J. H., Rosen, H., Miller, B. L., Zetterberg, H. & Boxer, A. L., Mar 1 2016, In : Annals of Clinical and Translational Neurology. 3, 3, p. 216-225 10 p.

Research output: Contribution to journalArticle

Progressive Supranuclear Palsy
Intermediate Filaments
Cerebrospinal Fluid

Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy

Tau Restoration on PSP (TAUROS) Investigators & The MDS-Endorsed PSP Study Group, May 1 2016, In : Movement Disorders. 31, 5, p. 742-747 6 p.

Research output: Contribution to journalArticle

Progressive Supranuclear Palsy
Placebo Effect
Clinical Trials
Activities of Daily Living